19/10/2026 07:40
EQS-Adhoc: DATA MODUL AG:
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: DATA MODUL AG / Key words: Results / Quarterbr/ DATA MODUL AG: br/br/ 19Oct2026 / 07:40 CET/CESTbr/ Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No... Lire...
19/10/2026 07:32
EQS-News: Steyr Motors AG: Voluntary public tender offer by SMOT Acquisition GmbH, a subsidiary of Red Cat Holdings, Inc. – Offer price of EUR 39.00 in cash
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Steyr Motors AG / Key words: Tender Offer br/ Steyr Motors AG: Voluntary public tender offer by SMOT Acquisition GmbH, a subsidiary of Red Cat Holdings, Inc. – Offer price of... Lire...
19/10/2026 07:31
EQS-Adhoc: Steyr Motors AG: Voluntary public tender offer by SMOT Acquisition GmbH, a subsidiary of Red Cat Holdings, Inc., for all shares in Steyr Motors AG
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Steyr Motors AG / Key words: Tender Offerbr/ Steyr Motors AG: Voluntary public tender offer by SMOT Acquisition GmbH, a subsidiary of Red Cat Holdings, Inc., for all shares in Steyr Motors AG... Lire...
19/10/2026 07:30
EQS-News: E+S Rück expects demand for high-quality reinsurance protection to remain strong in the German market
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Hannover Rück SE / Key words: Miscellaneous br/ ES Rück expects demand for highquality reinsurance protection to remain strong in the German market... Lire...
19/10/2026 07:30
EQS-News: Baader Trading Days 2026 attract strong interest
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Baader Bank AG / Key words: Miscellaneous br/ Baader Trading Days 2026 attract strong interest br/br/ 19.10.2026 / 07:30 CET/CESTbr/ The issuer is solely... Lire...
19/10/2026 07:30
ORPHAN SYNERGY EUROPE-PHARMA : OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
OSE Immunotherapeutics Reports Positive Topline Results of CombiTED Phase 2 Randomized Trial with Tedopi® OSE2101 in metastatic NonSmall Cell Lung Cancer • Topline results to be presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the... Lire...
19/10/2026 07:03
EQS-News: NORMA Group provides details on NewNORMA strategy and sets financial ambition through 2031
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: NORMA Group SE / Key words: Capital Markets Day br/ NORMA Group provides details on NewNORMA strategy and sets financial ambition through 2031 br/br/ 19.10.2026 / 07:03... Lire...
19/10/2026 07:02
EQS-Adhoc: Change to the dividend policy
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: NORMA Group SE / Key words: Dividend paymentsbr/ Change to the dividend policy br/br/ 19Oct2026 / 07:02 CET/CESTbr/ Disclosure of an inside information acc. to Article 17 MAR of the... Lire...
19/10/2026 07:00
Chocoladefabriken Lindt & Sprüngli AG : Lindt & Sprüngli announces leadership changes
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pChocoladefabriken Lindt & Sprüngli AG / Key words: Personnelbr/ Lindt & Sprüngli announces leadership changes br/br/ 19Oct2026 / 07:00 CET/CESTbr/ Release of an ad hoc announcement pursuant... Lire...